. SogaJFerlitoARinaldoA. Endocrinocarcinomas (carcinoids and their variants) of the larynx: a comparative consideration with those of other sites.Oral Oncol2004;40(7):668–72
2.
. RamseyMJNadolJBJrPilchBZ. Carcinoid tumor of the middle ear: clinical features, recurrences and metastases.Laryngoscope2005;115(9):1660–6
3.
. PatelYC. Somatostatin and its receptor family.Front Neuroendocrinology1999;20(3):157–198
4.
. ErikssonB. Medical treatment of gastroenteropancreatic tumors with octreotide plus interferon. In: The expanding role of octreotide I: advances in oncology:LambertsSWDogliotti, eds. Bristol: BioScientifica Books:2002. pp. 103–12
5.
. PanzutoFDi FonzoMIannicelliE. Long-term clinical outcome of somatostatin analogs for treatment of progressive, metastatic, well-differential entero-pancreatic endocrine carcinoma.Ann Oncol2006;17:461–6